Is Exeter Med Real Inc Legit?

Exeter Med Real Inc, despite its significant assets of over $42 million, consistently operates at a deficit, with expenses exceeding revenue in every reported period. For instance, in 2023, expenses were $8,529,701 against revenues of $7,253,698, indicating a shortfall of over $1.2 million. This trend of spending more than it earns raises concerns about long-term financial sustainability, especially given the consistent decline in assets from a peak of $49,284,002 in 2020 to $43,744,457 in 2023. The organization's transparency is commendable regarding executive compensation, reporting 0% officer compensation across all filings. This suggests that the organization's leadership is either unpaid or compensated through other means not classified as officer compensation, which warrants further investigation to fully understand the compensation structure. However, without a breakdown of program, administrative, and fundraising expenses, it's challenging to assess spending efficiency accurately. The consistent operating deficits, coupled with declining assets, suggest that Exeter Med Real Inc may be drawing down its reserves to cover operational costs. While the absence of officer compensation is a positive indicator of fiscal restraint at the top, the overall financial health appears strained due to persistent negative net income. A detailed analysis of expense categories is crucial to determine if the spending is primarily directed towards its mission or if administrative or other costs are disproportionately high.